Amedisys (STU:ADY) Total Liabilities : €871 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amedisys Total Liabilities?

Amedisys's Total Liabilities for the quarter that ended in Mar. 2024 was €871 Mil.

Amedisys's quarterly Total Liabilities declined from Sep. 2023 (€875.06 Mil) to Dec. 2023 (€862.34 Mil) but then increased from Dec. 2023 (€862.34 Mil) to Mar. 2024 (€871.44 Mil).

Amedisys's annual Total Liabilities increased from Dec. 2021 (€779.37 Mil) to Dec. 2022 (€820.97 Mil) and increased from Dec. 2022 (€820.97 Mil) to Dec. 2023 (€862.34 Mil).

Amedisys Total Liabilities Historical Data

The historical data trend for Amedisys's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Total Liabilities Chart

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

559.11

621.81

779.37

820.97

862.34

Amedisys Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															759.91	850.68	875.06	862.34	871.44

Amedisys Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Amedisys's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	434.402	+	(389.37	+	0.75100000000005
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	37.812	+	0)
	=	862

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1889.176	-	1026.841
	=	862

Amedisys's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	446.071	+	(384.836	+	0.76200000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	39.771	+	0)
	=	871

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1922.681	-	1051.242
	=	871

Amedisys Total Liabilities Related Terms

Thank you for viewing the detailed overview of Amedisys's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys (STU:ADY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (STU:ADY) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

AMED:USA ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (STU:ADY) Headlines

No Headlines